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ABSTRACT Many amyloid proteins form metastable soluble aggregates (or protoﬁbrils, or protein nanoparticles, with charac-
teristic sizes from ~10 to a few hundred nm). These can coexist with protein monomers and amyloid precipitates. These soluble
aggregates are key determinants of the toxicity of these proteins. It is therefore imperative to understand the physical basis
underlying their stability. Simple nucleation theory, typically applied to explain the kinetics of amyloid precipitation, fails to predict
such intermediate stable states. We examine stable nanoparticles formed by the Alzheimer’s amyloid-b peptide (40 and 42 resi-
dues), and by the protein barstar. These molecules have different hydrophobicities, and therefore have different short-range
attractive interactions between the molecules. We also vary the pH and the ionic strength of the solution to tune the long-range
electrostatic repulsion between them. In all the cases, we ﬁnd that increased long-range repulsion results in smaller stable nano-
particles, whereas increased hydrophobicity produces the opposite result. Our results agree with a charged-colloid type of model
for these particles, which asserts that growth-arrested colloid particles can result from a competition between short-range attrac-
tion and long-range repulsion. The nanoparticle size varies superlinearly with the ionic strength, possibly indicating a transition
from an isotropic to a linear mode of growth. Our results provide a framework for understanding the stability and growth of toxic
amyloid nanoparticles, and provide cues for designing effective destabilizing agents.INTRODUCTION
Amyloid aggregation of proteins is linked to various neuro-
degenerative diseases (1–5). The aggregation intermediates,
from dimers to the larger soluble aggregates, are thought to
significantly contribute to the toxicity of these amyloid
proteins. The relative toxicity contributions of the different
types of aggregates is still far from clear, but the soluble
aggregates (protofibrils or nanoparticles, >10 nm in size)
are suspected to be substantial contributors, e.g., in the
case of amyloid-b (which causes Alzheimer’s disease) (6–
12). Indeed, it has been shown that chemical agents (such
as Zn2þ) which can destabilize these nanoparticles also
reduce the toxicity of the peptides (7,13). Therefore, under-
standing the mechanism that ensures the stability of the
nanoparticles can provide directions for designing agents
that can destabilize them.
However, understanding this mechanism remains a signif-
icant unsolved problem. Simple nucleation theories suggest
that postnucleation particles should continue to grow indefi-
nitely in a saturated solution (14,15). The existence of a well-
defined saturation concentration, which is a thermodynamic
precondition for nucleation-mediated aggregation, has been
established (16). There is also ample evidence that the aggre-
gation of many of the common amyloid proteins occur via
a nucleation process (17,18). The size of this nucleus is
thought to be of approximately a few nm (11,19,20). The
lag-phase observed during the initial growth agrees with
the kinetics predicted by this model (17). Even the depen-
dence of the kinetics on supersaturation is well established,
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have been estimated from these measurements (19).
Although the existence of a post-nucleation stable state is
not predicted by the nucleation theory, metastable aggregates
of size 10 nm or larger are regularly found in an aggregating
solution (7,13). These bear similarity to the growth-arrested
colloid particles, which has been a system of recent interest
(21,22). Charged colloid particles can be stabilized by a
competition between short-range attractive and long-range
repulsive interactions (22). Small but stable lysozyme aggre-
gates (consisting of a few monomers), have been observed in
small angle neutron scattering experiments, and are sug-
gested to have the same origin as that of charged colloid clus-
ters (23). Though the inference regarding the lysozyme
aggregates have been debated (24), and the nanoparticles
investigated here are much larger, this suggests that a compe-
tition between short-range attraction and long-range repul-
sion may also be important in determining the stability of
the amyloid aggregates. Such a model would predict that
as a nanoparticle grows and the charge on it increases, the
electrostatic repulsion between the particle and an approach-
ing monomer increases. As the particle grows to a certain
characteristic size (and thus a sufficiently high charge), this
repulsion becomes large enough to drastically slow further
growth. However, the short-range attraction remains strong
enough to assimilate a monomer if it can come within a short
distance of the particle. The particles of this characteristic
size thus become metastable.
For the amyloid aggregates, we can independently vary the
two competing interactions, and can simultaneously measure
their effect on the size and the stability of the soluble aggre-
gates. The model predicts that if the average charge per
doi: 10.1016/j.bpj.2009.05.055
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away from the iso-electric point (pI) of the protein), or the
electrostatic screening by the aqueous solution is decreased
(which can be achieved by reducing the ionic strength), the
nanoparticle should reach stability at a smaller size. On the
other hand, if the hydrophobicity of the aggregating protein
increases, in effect increasing the short-range interaction,
the characteristic size should increase. If the characteristic
size is beyond a certain limit, these particles will precipitate
from the aqueous solution, in effect leaving the solution
void of any stable nanoparticles. The hydrophobic interac-
tions can be varied by introducing specific hydrophobic resi-
dues, or by creating the molten globule state of a suitable
protein using denaturants (for those proteins for which such
a state exists). This serves as a handle to tune the short-range
attraction. The particle sizes can be measured by using fluo-
rescence correlation spectroscopy (FCS) (25,26), employing
the maximum entropy method-based analysis routine
MEMFCS (27), as demonstrated by us previously (16,19).
Here we study the soluble aggregates formed by Alz-
heimer’s amyloid beta 1-40 (Ab1-40) and 1-42 (Ab1-42)
peptides. Both of these are known to cause neuropathologies,
and they differ by only two extra residues contained in Ab1-42,
such as Ile41 and Ala42. From the sequence, it appears likely
that the pI of the two peptides would be similar, but Ab1-42
would be more hydrophobic. With the given model, we
therefore expect that the Ab1-40 should form smaller-sized
soluble aggregates. These Ab1-40 aggregates have in fact
been characterized by us in previous experiments, and their
hydrodynamic radii range from tens to hundreds of nm
(7,13,16). If the aggregates of Ab1-42 are much bigger than
this, they would not be soluble, and would precipitate out of
the solution in due course.
We also study the aggregates formed by the protein barstar.
Barstar is a 10-kDa protein produced in Bacillus amylolique-
faciens as a ribonuclease inhibitor and is not related to any
known diseases, but is known to form amyloid aggregates
at a low pH (28–30). Barstar changes its folding pattern
with pH (31), forming a molten globule like state at pH values
at ~3. The pI of barstar is ~5.0 (32,33). This provides a unique
opportunity to test the charged colloid model. At physiolog-
ical pH, barstar is folded to a native state with well-buried
hydrophobic residues. At approximately pH 3.5, partial un-
folding results in exposed hydrophobic patches. The degree
of hydrophobicity can be quantified by the fluorescence of
the reporter dye ANS. At even lower pH (<3), these hydro-
phobic patches start to disappear, as the protein unfolds
further. In addition, the protein becomes increasingly posi-
tively charged. The charged colloid model would predict
that the soluble aggregates would start forming as we go
down from pH 7.4 to 3.5. However, as we move below this
pH, the aggregate sizes should start to reduce.
We test these predictions by determining the stability and
the size of the soluble aggregates using fluorescence correla-
tion spectroscopy (34–36).THEORY
We consider a heuristic model for understanding the depen-
dence of the size of the quasistable nanoparticle on the attrac-
tive and repulsive interactions in the system. For simplicity,
we presume that when a protein nanoparticle grows in
a supersaturated solution, the attractive interaction is solely
provided by short-range hydrophobic interaction. Although
an accurate analytical description of the hydrophobic interac-
tion as a function of distance is not available, it is known that
the major part of the interaction occurs at a length scale of
<1 nm (37). It is reasonable to assume that the spatial scale
is set by the thickness of a water layer (~0.2 nm), over which
the density of water near a nonpolar particle varies from its
bulk density (38). We also assume that the repulsive interac-
tion is provided by electrostatic interaction between the
growing nanoparticle and an approaching monomer. The
length scale of the repulsion is set by the Debye screening
length of the electrolyte solution (39), which is ~0.8 (2.5)
nm in the highest (lowest) ionic strength solution reported
here. Thus the range of the repulsive interaction remains
large compared to the range of the attractive interaction,
and we approximate the hydrophobic interaction by a nega-
tive step function extending up to the radius of the particle
a (though this assumption starts becoming inappropriate
for the highest ionic strengths). This is shown as a black
dotted line in Fig. 1.
The rate of growth of a solute nanoparticle in a supersatu-
rated solution is determined by the concentration of
FIGURE 1 Model potential function. The model consists of a repulsive
electrostatic potential screened by the ionic solution (solid line) and an
attractive hydrophobic potential (step function, black dotted line), which
are plotted here as functions of distance r from the center of the nanoparticle
of radius a. The value f0 is the maximum height of the potential, whereas f1
is the minimum of the potential. If the range of the attractive potential is not
infinitesimally short (e.g. see the gray dotted lines), f0 will change as the
depth of the potential changes from f1 to f2.Biophysical Journal 97(5) 1454–1460
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concentration is determined by the electrostatic potential at
the surface of the nanoparticle (f in Fig. 1). This assumes
that the monomer concentration near the accreting nanopar-
ticle remains close to its bulk value. This is a reasonable
assumption provided the growth rate is sufficiently slow.
The concentration of the monomers C(a) at the surface of
a nanoparticle of radius a is given as
CðaÞ ¼ CNefðaÞq=kT ; (1)
where CN is the bulk concentration of monomers, q is the
charge of a monomer unit, k is the Boltzmann constant, T
is the temperature of the system, and f(a) is the electrostatic
potential at the surface of the nanoparticle, which in an ionic
solution is given as (39,40)
fðaÞ ¼ Zq=3að1 þ kaÞ; (2)
where Z is the total number of monomers constituting the
nanoparticle, 3 is the dielectric constant of the medium,
and k is the screening parameter, defined as
k ¼ 8pN0q2I=10003kT
1=2
: (3)
Here N0 is the Avogadro’s number and I is the ionic strength
of the solution in moles/L, whereas other quantities are in cgs
units.
The total number of monomers Z in the nanoparticle is
given by
Z ¼ a3=a30; (4)
where a0 is the radius of an individual monomer unit. There-
fore to obtain the same repulsive potential, fa on the surface
of nanoparticles at different ionic strengths, Eqs. 2–4 implies
(assuming ka[ 1, true for experiments described here)
afI1=2: (5)
As the particle grows, the total number of charged monomers
(Z) on the nanoparticle no longer grows as a3, since the free
energy cost of burying a charge inside a hydrophobic particle
is rather high. In the limit, when a becomes large, and if the
particle is reasonably compact with a water-inaccessible
core, Z would vary as a2. Alternatively, the particle can also
grow linearly (i.e., as a cylinder) and not spherically, which
would also make Z proportional to a2. In that limit, a becomes
independent of I. We therefore expect to see a transition
between a growing as I1/2 at small ionic strengths, to a,
becoming independent of I at large ionic strengths. This would
manifest as a sublinear to a superlinear transition in the depen-
dence of a on I in the intermediate range of ionic strengths.
This model can also be used to understand the effect of pH
on the radius of a stable nanoparticle. At a given ionic
strength, q increases as we move away from the pI of the
peptide. Therefore, the same electrostatic potential f0 will
now be formed at a smaller size of the nanoparticle, as
evident from Eqs. 2 and 4.
Biophysical Journal 97(5) 1454–1460In this approximation, the hydrophobic potential has no
effect on f0, irrespective of its magnitude (see f1 and f2,
Fig. 1). However, in reality, the range of the attractive poten-
tial does extend beyond r ¼ a (gray dashed line, Fig. 1). If
the amplitude of the hydrophobic attractive potential
increases, the approximation that the electrostatic potential
is governed by Eq. 2 close to the surface will become a
poor one. The potential maximum will occur further away
from the surface, and the value of the barrier will be lowered
by the enhanced attractive interaction as can be summarized
from Fig. 1. Therefore, increased short-range attraction will
lead to larger nanoparticles at the same ionic strength.
MATERIALS AND METHODS
Protein expression and puriﬁcation
Barstar was expressed and purified as described before (41) and used as
such. Ab1-40 and Ab1-42 were purchased from rPeptide (Bogart, GA) and
were used as such.
Thioﬂavin-T binding assay
Thioflavin-T (thio-T) is purchased from Sigma Chemicals (St. Louis, MO)
and was used as such. The protein samples are prepared in buffers containing
5 mM thio-T. The thio-T fluorescence is recorded in a Fluoromax 3 fluorim-
eter (SPEX CertiPrep, Stanmore, UK) using an excitation wavelength of
444 nm and an emission wavelength of 488 nm.
Fluorescence correlation spectroscopy (FCS)
Barstar C82A is labeled at Cys40 with tetramethyl rhodamine iodoacetate
using the protocol supplied by Molecular Probes (Carlsbad, CA). This
labeled protein is used at a ratio of 1:1000 to the unlabeled barstar. Rhoda-
mine-labeled Ab1-40 and Ab1-42 were purchased from rPeptide. These are
used at a ratio of 1:1000 to the unlabeled peptides. FCS measurements are
performed in an FCS instrument constructed in-house as described else-
where (27). The data are analyzed with the MEMFCS fitting routine (27).
RESULTS
Soluble aggregates of Ab1-40 and Ab1-42 at pH 7.4
Solutions of each of these peptides were prepared in HEPES
buffer at pH 7.4, starting from a stock solution of 230 mM
prepared in water at pH 10.5 (the solubility of these peptides
are much higher under this condition). The solutions are aged
for 2 h. They are then centrifuged at 2000 g for 20 min and
the supernatant is collected for FCS experiments. The corre-
lation data of these solutions, together with a calibration
solution of rhodamine B, is analyzed with the MEMFCS
analysis routine in terms of a quasicontinuous distribution
of diffusion times (27). The diffusion times are converted
into hydrodynamic radii using rhodamine B as a calibrant
(hydrodynamic radius ¼ 0.78 nm) (42).The size distribution
obtained from the analysis is shown in Fig. 2 (Ab1-40 is
shown as circles, whereas Ab1-42 is shown as squares).
We see that Ab1-40 forms soluble aggregates of ~200 nm,
but the Ab1-42 solution does not show any large soluble
Stability of Toxic Soluble Aggregates 1457aggregates at this pH. However, the Ab1-42 solution shows
considerable precipitation, indicating that any stable aggre-
gate, if it does exist, is too large to be soluble.
Soluble aggregate formation in Ab1-42 solution
as a function of pH
To investigate whether Ab1-42 may yield soluble aggregates
at a different pH, we prepare the Ab1-42 solutions of pH 7.4,
9.0, 10.5, and 12.0, and measure the size distribution with
FCS. The size distributions obtained from these solutions
are shown in Fig. 3 (open squares, pH 7.4; solid stars, pH
9.0; open circles, pH 10.5; and solid squares, pH 12.0).
FIGURE 2 Size distribution of Ab1-40 versus Ab1-42. Size distribution of
Ab1-40 (circles) and Ab1-42 (squares) obtained by MEMFCS analysis of the
fluorescence correlation spectroscopy data.
FIGURE 3 Size distribution of Ab1-42 at different values of pH. The size
distributions obtained by MEMFCS analysis of FCS data at pH 7.4 (open
squares), pH 9.0 (solid stars), pH 10.5 (open circles), and pH 12.0 (solid
squares).We see that the pH 7.4 and the pH 9.0 solutions do not
show any tendency to form soluble aggregates. However,
the peak gets broader at pH 10.5, indicating the formation
of some soluble aggregates. At pH 12.0, the second peak
is separate and pronounced, and shows aggregates of size
~50 nm. An increased charge per monomer thus corresponds
to a smaller size for the stable nanoparticle.
Soluble aggregates of Ab1-42 at different ionic
strengths
The size determination experiment was then performed in
phosphate-buffered solutions at pH 12.0 at six different ionic
strengths, i.e., 0, 25, 50, 75, 100, 125, and 150 mM of NaCl
(effective approximate ionic strengths of 17, 42, 67, 92, 117,
142, and 167 mM, respectively, taking into account the
buffer and other minor salts). The correlation curves are
shown in Fig. 4 a and the analysis of the curves in terms
of the sizes is shown in Fig. 4 b. A proper MEMFCS analysis
is not possible for all of these curves, as at higher ionic
strengths the sizes become too big and bleaching related arti-
facts cannot be neglected. The analysis in Fig. 4 b therefore
only considers the t1/2 times of the correlation curves, and
provides an approximate measure of the sizes of the particles.
The correlation curves clearly show a monotonic increase of
the characteristic diffusion time (and therefore the average
particle size) as the ionic strength increases.
Soluble aggregates of barstar as a function of pH
We prepare 10 mM barstar solutions containing 0.2% of
rhodamine-labeled barstar at three different pH values (7.4,
3.5, and 2.0) and incubate these overnight. The solutions
are then centrifuged at 2000  g for 20 min and the superna-
tants are probed with FCS. Fig. 5 shows the plots of the size
distributions obtained at different values of pH (pH 7.4,
squares; pH 3.5, circles; and pH 2.0, triangles). Whereas
the solution at pH 7.4 shows no large particles, at pH 3.5
we observe soluble aggregates approximately tens of nm in
size. At the lower pH of 2.0, the soluble aggregates exhibit
a smaller size range (between 10 and 20 nm). Both the lower
pH values also show an additional peak at smaller sizes, at
~0.8 nm, which is similar to the hydrodynamic radius of
the calibrant rhodamine B, and probably indicate the pres-
ence of dissociated dye molecules in the solution.
The degree of hydrophobicity of individual monomers is
measured by the binding of the polarity sensitive dye ANS.
This is shown in Fig. 5 (inset) as a function of pH. ANS binding
goes up as the pH is decreased, and peaks at approximately pH
3, but decreases below that. The solution is also probed for
thio-T binding, which is supposed to report the formation of
the repeatedb-sheet structures in a protein (43). There is hardly
any change in thio-T fluorescence until the pH reaches ~5.0.
However, it then rapidly goes up and becomes maximum at
approximately pH 3.5, and then starts going down gradually
as the pH is lowered further (data not shown).Biophysical Journal 97(5) 1454–1460
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We have used pH, ionic strength, and addition of hydro-
phobic residues as modulators of the long-range electrostatic
repulsion and short-range hydrophobic attraction between
the aggregating mono- and oligomers. It is not possible to
cleanly partition the contribution of any of these agents to
these two factors. However, it is expected that for Ab1-40,
the variation of pH and ionic strength would predominantly
affect the electrostatic interaction, whereas the addition of
the hydrophobic residues would mostly affect the short-
range hydrophobic interaction.
Ab1-40 at pH 7.4 forms stable soluble aggregates of size at
~200 nm. The hydrophobicity of this peptide can be easily
a
b
FIGURE 4 Size of nanoparticles as a function of the ionic strength. (a)
Autocorrelation curves. Ionic strengths of 17 mM (solid squares), 42 mM
(open squares), 67 mM (solid circles), 92 mM (solid stars), 117 mM (open
stars), 142 mM (open circles), and 167 mM (solid triangles), respectively.
(b) Relative sizes of Ab1-42 at a function of ionic strength of the solution.
Biophysical Journal 97(5) 1454–1460increased by adding hydrophobic residues to the sequence,
and Ab1-42 provides a natural variant of this type. Ab1-42
shows no large aggregates (Fig. 2). However, the concentra-
tion in the supernatant goes down rapidly during incubation
(data not shown) and there is visible precipitation from this
solution, indicating that aggregation does take place. We
infer that the Ab1-42 nanoparticles do not stabilize at a small
enough size to be soluble in aqueous solutions. The effect of
increased hydrophobic interaction is consistent with the
model represented in Fig. 1 (gray dashed lines).
The results change when the pH is altered (Fig. 3). Though
the pH 9.0 solution behaves much like the pH 7.4 solution,
there is a clear indication of the presence of soluble nanopar-
ticles at pH 10.5. At an even higher pH of 12.0, there is a
pronounced peak due to soluble nanoparticles of size ~50 nm.
Ab1-40 has a pI at approximately pH 5.3 (44). However, an
analysis of the amino-acid sequence (taking into consider-
ation the individual pKa values of the amino acids as guide-
lines) suggests that it is only weakly charged until pH 9, but
becomes multipally charged at pH 10.5 and even more
strongly charged at pH 12. This indicates that the increase
in the charge per monomer caused by the increase in the pH
stabilizes the growing particles at smaller sizes. These results
agree with the predictions made earlier, and therefore corrob-
orate the overall features of the charged colloid model (23,45).
We do note that the possibility of a change of the secondary
structure with pH may also contribute to this behavior.
The ionic strength variations provide further tests of the
model. A pronounced and monotonous decrease of the
particle size is observed as the ionic strength is decreased
(Fig. 4 b). The screening of the repulsive field is decreased
at lower ionic strengths, and therefore the long-range repul-
sion increases, which tends to stabilize nanoparticles at
FIGURE 5 Size distribution of barstar as a function of pH. At pH 7.4
(squares), pH 3.5 (circles), and pH 2.0 (triangles) obtained from FCS
data. (Inset) ANS fluorescence reporting barstar hydrophobicity at several
pH values. Abscissa, pH values; and ordinate, ANS fluorescence intensity
in arbitrary units.
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is consistent with this prediction. Equation 5 would predict
that the radius of a stable nanoparticle would vary as I1/2,
but the observed behavior is clearly superlinear. As dis-
cussed in the Theory section, such a behavior is expected
for a range of ionic strengths, and possibly suggests a transi-
tion from an isotropic pattern of growth to a linear pattern of
growth. Johansson et al. (46) have measured the rate of fibril
formation as a function of the ionic strength, and they find
that the rate increases with the ionic strength. This also is
clearly consistent with our results. We note that the hydro-
phobic effect itself is also a function of the salt concentration
(47), increasing with the increase of the ionic strength.
However, this effect is typically small at these salt concentra-
tions, and we take these results as further evidence for the
charged colloid model.
The barstar results provide further support to our model.
This protein is properly folded and completely soluble at a
pH of 7.4. As the pH is lowered, two properties change. First,
the hydrophobicity of the protein surface increases, as is
shown by the increased ANS fluorescence (Fig. 5, inset).
This is consistent with the protein slowly transforming to
its A-form (28,29), which is a molten globulelike state.
However, this reaches a peak at 3.5, and decreases upon
further decrease of the pH, as the molten globule state is
increasingly replaced by a random coil-like state. Addition-
ally, the monomers get increasingly charged at lower pH
values, as it goes further away from the pI of ~5. The model
would therefore predict possible stable nanoparticles at
pH~3.5 and smaller nanoparticles at lower pH values. This
is indeed observed. The thio-T binding data further shows
the amyloidlike nature of the nanoparticles at these pH
values. We infer that the soluble amyloid aggregates of a
larger size range are stabilized when the protein monomers
are more hydrophobic and less charged.
The validity of the charge colloid model suggests that a
molecular agent that can increase the short-range attraction
(its strength and /or its range; see Fig. 1, gray dashed lines)
can be a very effective agent for destabilizing the nanopar-
ticles. It has been suggested that Zn2þ can potentially
cross-link multiple Ab monomers (48). A cross-linker would
in effect increase the short-range attraction between Ab
monomers. It would also increase the range of interaction
close to that of the length of a single Ab molecule, which
is approximately the Debye screening length. This should
push the nanoparticles to higher sizes and precipitate them,
leading to a lowering of Ab toxicity. This has indeed been
observed recently (7).
Overall, the evidence from the proteins and peptides
examined by us, and other preexisting data, strongly suggest
that the charged colloid model correctly describes the size
and the stability of the soluble aggregates of amyloid protein.
The model therefore provides a simple logical framework for
designing agents (e.g., Ab cross-linkers) that can modulate
the stability of protein nanoparticles.The barstar protein was expressed and purified using clones and facilities
available in the laboratory of Jayant Udgaonkar. We thank Deepak Dhar
for fruitful discussions on the theory of aggregation of charged colloids.
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